
Adamis Pharmaceuticals Corporation ADMP
Quarterly report 2023-Q3
added 06-06-2026
Adamis Pharmaceuticals Corporation P/S Ratio 2011-2026 | ADMP
Annual P/S Ratio Adamis Pharmaceuticals Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.78 | 39.2 | 32.1 | 1.59 | 7.95 | 7.92 | 8.38 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 39.2 | 1.59 | 14.4 |
P/S Ratio of other stocks in the Drug manufacturers industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Endo International plc
ENDP
|
0.0339 | - | - | $ 28.9 M | ||
|
Evoke Pharma
EVOK
|
0.036 | - | - | $ 36.6 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
6.2 | $ 5.49 | -2.23 % | $ 81.6 M | ||
|
HEXO Corp.
HEXO
|
1.44 | - | 2.45 % | $ 38.1 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
1.44 K | - | -0.1 % | $ 2.03 B | ||
|
AcelRx Pharmaceuticals
ACRX
|
18.8 | - | 7.5 % | $ 6.35 M | ||
|
DURECT Corporation
DRRX
|
12.3 | - | - | $ 50.1 M | ||
|
Aerie Pharmaceuticals
AERI
|
1.68 | - | - | $ 754 M | ||
|
Agile Therapeutics
AGRX
|
0.066 | - | 10.11 % | $ 58.2 M | ||
|
Alimera Sciences
ALIM
|
1.26 | - | - | $ 142 M | ||
|
Cronos Group
CRON
|
5.02 | $ 2.68 | 0.19 % | $ 1.03 B | ||
|
Athenex
ATNX
|
0.111 | - | -23.39 % | $ 1.76 M | ||
|
Harrow Health
HROW
|
7.1 | $ 42.18 | 0.57 % | $ 1.55 B | ||
|
Avadel Pharmaceuticals plc
AVDL
|
4.24 | - | - | $ 2.06 B | ||
|
Catalent
CTLT
|
2.48 | - | - | $ 11.5 B | ||
|
Eagle Pharmaceuticals
EGRX
|
1.07 | - | -39.89 % | $ 27.7 M | ||
|
Organogenesis Holdings
ORGO
|
0.598 | $ 2.44 | 4.06 % | $ 309 M | ||
|
Pacira BioSciences
PCRX
|
5.13 | $ 22.38 | -1.15 % | $ 1.03 B | ||
|
Canopy Growth Corporation
CGC
|
1.03 | $ 0.96 | 1.88 % | $ 286 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
0.0949 | $ 1.12 | -2.61 % | $ 1.89 M | ||
|
Aurora Cannabis
ACB
|
0.0941 | $ 2.94 | 0.68 % | $ 161 M | ||
|
Solid Biosciences
SLDB
|
4.76 | $ 7.86 | 7.52 % | $ 688 M | ||
|
Jupiter Wellness
JUPW
|
3.37 | - | - | $ 33.6 M | ||
|
Lannett Company
LCI
|
0.0675 | - | 1.15 % | $ 7.11 M | ||
|
OrganiGram Holdings
OGI
|
0.942 | $ 0.98 | -1.14 % | $ 93.4 M | ||
|
Tilray
TLRY
|
1.9 | $ 4.7 | -1.05 % | $ 2.9 B | ||
|
Veru
VERU
|
0.639 | $ 2.98 | -0.33 % | $ 43.6 M | ||
|
Evolus
EOLS
|
0.913 | $ 6.62 | -1.85 % | $ 427 M | ||
|
Sundial Growers
SNDL
|
0.0158 | $ 1.42 | -1.74 % | $ 3.37 M | ||
|
Emergent BioSolutions
EBS
|
0.609 | $ 8.02 | -1.35 % | $ 429 M | ||
|
Neoleukin Therapeutics
NLTX
|
2.11 | - | - | $ 193 M | ||
|
cbdMD
YCBD
|
0.187 | $ 0.69 | 1.1 % | $ 2.78 M | ||
|
Assertio Holdings
ASRT
|
0.635 | - | - | $ 150 M | ||
|
ProPhase Labs
PRPH
|
1.06 | - | - | $ 5.07 M | ||
|
Radius Health
RDUS
|
1.71 | - | - | $ 1.42 B | ||
|
Bausch Health Companies
BHC
|
0.198 | $ 4.72 | -0.63 % | $ 1.75 B | ||
|
PetIQ
PETQ
|
0.36 | - | 1.64 % | $ 400 M | ||
|
Recro Pharma
REPH
|
1.41 | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
0.18 | - | - | $ 1.08 B | ||
|
SCYNEXIS
SCYX
|
1.84 | $ 3.94 | 3.8 % | $ 197 M | ||
|
PLx Pharma
PLXP
|
14.6 | - | -27.8 % | $ 2.56 M | ||
|
Viatris
VTRS
|
1.19 | $ 15.24 | -3.15 % | $ 17.7 B | ||
|
Zomedica Corp.
ZOM
|
5.45 | - | -0.21 % | $ 98 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
933 | - | - | $ 55.5 M | ||
|
Rockwell Medical
RMTI
|
0.488 | $ 0.66 | 1.11 % | $ 23.7 M | ||
|
China Pharma Holdings
CPHI
|
0.663 | $ 0.77 | -8.19 % | $ 3.3 M | ||
|
TherapeuticsMD
TXMD
|
7.62 | $ 2.13 | -6.39 % | $ 24.6 M |